Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Por tema
173896 ARTíCULOS , VIENDO DEL 173536 AL 173550
Alieva A, Rudenok M, Filatova E, Karabanov A, Doronina O, Doronina K, Kolacheva A, Ugrumov M, Illarioshkin S, Slominsky P, Shadrina M.
Sci Rep. 2020 Jan 21;10(1):827. doi: 10.1038/s41598-020-57938-3.
0
0
0
Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease
Jin W.
J Clin Med. 2020 Jan 17;9(1):257. doi: 10.3390/jcm9010257.
0
0
0
Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease
Sironi L, Restelli LM, Tolnay M, Neutzner A, Frank S.
Cells. 2020 Jan 17;9(1):233. doi: 10.3390/cells9010233.
0
0
0
TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease
Muñoz MD, de la Fuente N, Sánchez-Capelo A.
Int J Mol Sci. 2020 Jan 16;21(2):590. doi: 10.3390/ijms21020590.
0
0
0
Wu YN, Chen MH, Chiang PL, Lu CH, Chen HL, Yu CC, Chen YS, Chang YY, Lin WC.
J Clin Med. 2020 Jan 16;9(1):239. doi: 10.3390/jcm9010239.
0
0
0
Liu Z, He S, Li L.
Stereotact Funct Neurosurg. 2020 Jan 21:1-10. doi: 10.1159/000505079. [Epub ahead of print] Review.
0
0
0
Brooks C, Shaafi Kabiri N, Mortazavi F, Auerbach S, Bonato P, Erb MK, Czech M, Karlin D, Rolph T, Bhangu J, Thomas K.
Chronobiol Int. 2020 Jan 21:1-13. doi: 10.1080/07420528.2020.1715998. Online ahead of print.
0
0
0
Characterization of a Parkinson's disease rat model using an upgraded paraquat exposure paradigm
Cristóvão AC, Campos FL, Je G, Esteves M, Guhathakurta S, Yang L, Beal MF, Fonseca BM, Salgado AJ, Queiroz J, Sousa N, Bernardino L, Alves G, Yoon KS, Kim YS.
Eur J Neurosci. 2020 Jan 20. doi: 10.1111/ejn.14683. Online ahead of print.
0
0
0
Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score
Iwaki H, Blauwendraat C, Makarious MB, Bandrés-Ciga S, Leonard HL, Gibbs JR, Hernandez DG, Scholz SW, Faghri F; International Parkinson's Disease Genomics Consortium (IPDGC), Nalls MA, Singleton AB.
Mov Disord. 2020 May;35(5):774-780. doi: 10.1002/mds.27974. Epub 2020 Jan 20.
0
0
0
von Linstow CU, DeLano-Taylor M, Kordower JH, Brundin P.
J Parkinsons Dis. 2020;10(2):405-411. doi: 10.3233/JPD-191877.
0
0
0
Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person
Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, Kwok K, Cannon P, Marek K,
J Parkinsons Dis. 2020;10(2):677-691. doi: 10.3233/JPD-191808.
0
0
0
Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, Hölscher C.
J Parkinsons Dis. 2020;10(2):523-542. doi: 10.3233/JPD-191768.
0
0
0
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment
Cesarone MR, Belcaro G, Hosoi M, Ledda A, Feragalli B, Maione C, Scipione C, Scipione V, Cotellese R, Hu S.
J Neurosurg Sci. 2020 Jun;64(3):258-262. doi: 10.23736/S0390-5616.19.04839-2. Epub 2020 Jan 20.
0
0
0
Zhu L, Duval C, Boissy P, Montero-Odasso M, Zou G, Jog M, Speechley M.
J Gerontol A Biol Sci Med Sci. 2020 Nov 13;75(12):2361-2370. doi: 10.1093/gerona/glaa012.
0
0
0
State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease
Quarracino C, Otero-Losada M, Capani F, Pérez-Lloret S.
Expert Opin Pharmacother. 2020 Mar;21(4):445-457. doi: 10.1080/14656566.2020.1713097. Epub 2020 Jan 20.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
